IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: United States/Americas

Axa Private Equity Buys Active Ingredient Business

12:53 PM MDT | April 18, 2008 | Esther D’Amico

Health and nutrition product firm Atrium (Quebec City) says it has agreed to sell its active ingredient and specialty chemical division to Axa Private Equity (Paris) for $155 million in cash. The deal is expected to generate total proceeds of more than $165 million, subject to working capital adjustments, and is expected to close by mid-May, pending customary approvals. Charles Boulanger will continue as president of the division, which will also retain its current management team, Atrium says. The deal does not include Atrium’s Quebec City manufacturing...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily newsvv and analysis from the entire global chemical enterprise on chemweek.com
  • Free mobile edition of Chemical Week
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional focus
  • Global outlook issue

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa